Lilly Schwieler

Publications
CV
Public outreach and news

Articles

Article: MEDICINE & SCIENCE IN SPORTS & EXERCISE. 2024;56(10):2007-2015
Mood, Cognitive Function, and Plasma Kynurenine Metabolites Responses Following Severe Changes in Physical Activity
Kamandulis S; Lukonaitiene I; Snieckus A; Brazaitis M; Mickevicius M; Cernych M; Ruas J; Schwieler L; Louvrou V; Erhardt S; Westerblad H; Venckunas T
Journal article: INFECTIOUS DISEASES. 2024;56(9):732-742
Long-term neurological and neurocognitive impairments after tick-borne encephalitis in Lithuania - a prospective study
Griska V; Pranckeviciene A; Pakalniene J; Gabrijolaviciute D; Veje M; Studahl M; Ahlberg J; Schwieler L; Lindquist L; Mickiene A
Article: INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH. 2024;17:11786469241245323
Kynurenine Metabolites in CSF and Plasma in Healthy Males
Orhan F; Schwieler L; Engberg G; Samuelsson M
Journal article: INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH. 2024;17:11786469241262876
The Tryptophan Metabolite Indole-3-Propionic Acid Raises Kynurenic Acid Levels in the Rat Brain In Vivo
Sathyasaikumar KV; Blanco-Ayala T; Zheng Y; Schwieler L; Erhardt S; Tufvesson-Alm M; Poeggeler B; Schwarcz R
Article: ACTA NEUROPSYCHIATRICA. 2023;:1-13
Dual administration of lipopolysaccharide induces behavioural changes in rats relevant to psychotic disorders
Zheng Y-R; Tufvesson-Alm M; Trepci A; Imbeault S; Li X-Q; Schwieler L; Engberg G; Erhardt S
Article: BRAIN, BEHAVIOR, AND IMMUNITY. 2023;111:376-385
Immunological protein profiling of first-episode psychosis patients identifies CSF and blood biomarkers correlating with disease severity
Eren F; Schwieler L; Orhan F; Malmqvist A; Piehl F; Cervenka S; Sellgren CM; Fatouros-Bergman H; Engberg G; Erhardt S
Article: PSYCHONEUROENDOCRINOLOGY. 2023;153:106110
Lipopolysaccharide-induced changes in the kynurenine pathway and symptoms of sickness behavior in humans
Balter LJT; Li X; Schwieler L; Erhardt S; Axelsson J; Olsson MJ; Lasselin J; Lekander M
Article: SCHIZOPHRENIA RESEARCH. 2023;257:34-40
CSF dopamine is elevated in first-episode psychosis and associates to symptom severity and cognitive performance
Orhan F; Goiny M; Becklen M; Mathe L; Piehl F; Schwieler L; Fatouros-Bergman H; Farde L; Cervenka S; Sellgren CM; Engberg G; Erhardt S
Article: LEUKEMIA. 2023;37(4):888-900
Cognitive impairments correlate with increased central nervous system immune activation after allogeneic haematopoietic stem cell transplantation
Boberg E; Kadri N; Hagey DWW; Schwieler L; El Andaloussi S; Erhardt S; Iacobaeus E; Le Blanc K
Journal article: NEUROSCIENCE APPLIED. 2023;2:103551
Kynurenic acid promotes activity-dependent synaptic pruning and associates with genetic risk variance for schizophrenia
Orhan F; Malwade S; Schwieler L; Tiihonen J; Koistinahu J; Erhardt S; Engberg G; Kent J; Samudyata S; Sellgren C
Article: NATURE COMMUNICATIONS. 2022;13(1):6427
Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia
Gracias J; Orhan F; Horbeck E; Holmen-Larsson J; Khanlarkani N; Malwade S; Goparaju SK; Schwieler L; Demirel IS; Fu T; Fatourus-Bergman H; Pelanis A; Goold CP; Goulding A; Annerbrink K; Isgren A; Sparding T; Schalling M; Yanez VAC; Gopfert JC; Nilsson J; Brinkmalm A; Blennow K; Zetterberg H; Engberg G; Piehl F; Sheridan SD; Perlis RH; Cervenka S; Erhardt S; Landen M; Sellgren CM
Article: BRITISH JOURNAL OF NUTRITION. 2022;129(6):1-8
Two-day fasting affects kynurenine pathway with additional modulation of short-term whole-body cooling: a quasi-randomised crossover trial
Solianik R; Schwieler L; Trepci A; Erhardt S; Brazaitis M
Article: TRANSLATIONAL PSYCHIATRY. 2022;12(1):229
Identification of cerebrospinal fluid and serum metabolomic biomarkers in first episode psychosis patients
Shang P; Ho AM-C; Tufvesson-Alm M; Lindberg DR; Grant CW; Orhan F; Eren F; Bhat M; Engberg G; Schwieler L; Fatouros-Bergman H; Imbeault S; Iverson RM; Dasari S; Piehl F; Cervenka S; Sellgren CM; Erhardt S; Choi D-S
Article: BRAIN, BEHAVIOR, AND IMMUNITY. 2022;101:136-145
Peripheral and central kynurenine pathway abnormalities in major depression
Paul ER; Schwieler L; Erhardt S; Boda S; Trepci A; Kampe R; Asratian A; Holm L; Yngve A; Dantzer R; Heilig M; Hamilton JP; Samuelsson M
Journal article: BRAIN, BEHAVIOR, AND IMMUNITY. 2021;98:50
Inflammation moderates stress resilience and ketamine response in male antidepressant-resistant rats
Price JB; Walker AJ; Yates C; Erhardt S; Schwieler L; Tye SJ
Article: MOLECULAR PSYCHIATRY. 2021;26(11):6820-6832
GRK3 deficiency elicits brain immune activation and psychosis
Sellgren CM; Imbeault S; Larsson MK; Oliveros A; Nilsson IAK; Codeluppi S; Orhan F; Bhat M; Tufvesson-Alm M; Gracias J; Kegel ME; Zheng Y; Faka A; Svedberg M; Powell SB; Caldwell S; Kamenski ME; Vawter MP; Schullman A; Goiny M; Svensson CI; Hokfelt T; Schalling M; Schwieler L; Cervenka S; Choi D-S; Landen M; Engberg G; Erhardt S
Article: ANTIOXIDANTS. 2021;10(9):1443
Vitamin C and E Treatment Blocks Changes in Kynurenine Metabolism Triggered by Three Weeks of Sprint Interval Training in Recreationally Active Elderly Humans
Wyckelsma VL; Trepci A; Schwieler L; Venckunas T; Brazaitis M; Kamandulis S; Paulauskas H; Gapeyeva H; Paasuke M; Gastaldello S; Imbeault S; Westerblad H; Erhardt S; Andersson DC
Article: JOURNAL OF NEUROINFLAMMATION. 2021;18(1):158
Intravenous administration of LPS activates the kynurenine pathway in healthy male human subjects: a prospective placebo-controlled cross-over trial
Millischer V; Heinzl M; Faka A; Resl M; Trepci A; Klammer C; Egger M; Dieplinger B; Clodi M; Schwieler L
Article: MICROORGANISMS. 2021;9(2):322
The Kynurenine Pathway is Differentially Activated in Children with Lyme Disease and Tick-Borne Encephalitis
Wickstrom R; Fowler A; Goiny M; Millischer V; Ygberg S; Schwieler L
Article: SCHIZOPHRENIA RESEARCH. 2021;228:118-123
Disrupted sensorimotor gating in first-episode psychosis patients is not affected by short-term antipsychotic treatment
Hedberg M; Imbeault S; Erhardt S; Schwieler L
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021;43:52-62
Central levels of tryptophan metabolites in subjects with bipolar disorder
Trepci A; Sellgren CM; Palsson E; Brundin L; Khanlarkhani N; Schwieler L; Landen M; Erhardt S
Article: SCIENTIFIC REPORTS. 2021;11(1):1669
Differential effects on blood and cerebrospinal fluid immune protein markers and kynurenine pathway metabolites from aerobic physical exercise in healthy subjects
Isung J; Granqvist M; Trepci A; Huang J; Schwieler L; Kierkegaard M; Erhardt S; Jokinen J; Piehl F
Article: JOURNAL OF NEUROIMMUNOLOGY. 2020;349:577401
Repeated administration of LPS exaggerates amphetamine-induced locomotor response and causes learning deficits in mice
Tufvesson-Alm M; Imbeault S; Liu X-C; Zheng Y; Faka A; Choi D-S; Schwieler L; Engberg G; Erhardt S
Article: BIOLOGICAL PSYCHIATRY: COGNITIVE NEUROSCIENCE AND NEUROIMAGING. 2020;5(12):1095-1103
Brain Age Prediction Reveals Aberrant Brain White Matter in Schizophrenia and Bipolar Disorder: A Multisample Diffusion Tensor Imaging Study
Tonnesen S; Kaufmann T; de Lange A-MG; Richard G; Nhat TD; Alnaes D; van der Meer D; Rokicki J; Moberget T; Maximov II; Agartz I; Aminoff SR; Beck D; Barch DM; Beresniewicz J; Cervenka S; Fatouros-Bergman H; Craven AR; Flyckt L; Gurholt TP; Haukvik UK; Hugdahl K; Johnsen E; Jonsson EG; Kolskar KK; Kroken RA; Lagerberg TV; Loberg E-M; Nordvik JE; Sanders A-M; Ulrichsen K; Andreassen OA; Westlye LT
Article: EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2020;270(7):933-938
Twin study shows association between monocyte chemoattractant protein-1 and kynurenic acid in cerebrospinal fluid
Johansson V; Erhardt S; Engberg G; Kegel M; Bhat M; Schwieler L; Blennow K; Zetterberg H; Cannon TD; Wetterberg L; Hultman CM; Landen M
Article: NATURE COMMUNICATIONS. 2020;11(1):4016
The genetic architecture of human brainstem structures and their involvement in common brain disorders
Elvsashagen T; Bahrami S; van der Meer D; Agartz I; Alnaes D; Barch DM; Baur-Streubel R; Bertolino A; Beyer MK; Blasi G; Borgwardt S; Boye B; Buitelaar J; Boen E; Celius EG; Cervenka S; Conzelmann A; Coynel D; Di Carlo P; Djurovic S; Eisenacher S; Espeseth T; Fatouros-Bergman H; Flyckt L; Franke B; Frei O; Gelao B; Harbo HF; Hartman CA; Haberg A; Heslenfeld D; Hoekstra PJ; Hogestol EA; Jonassen R; Jonsson EG; Kirsch P; Kloszewska I; Lagerberg TV; Landro NI; Le Hellard S; Lesch K-P; Maglanoc LA; Malt UF; Mecocci P; Melle I; Meyer-Lindenberg A; Moberget T; Nordvik JE; Nyberg L; O'Connell KS; Oosterlaan J; Papalino M; Papassotiropoulos A; Pauli P; Pergola G; Persson K; de Quervain D; Reif A; Rokicki J; van Rooij D; Shadrin AA; Schmidt A; Schwarz E; Selbaek G; Soininen H; Sowa P; Steen VM; Tsolaki M; Vellas B; Wang L; Westman E; Ziegler GC; Zink M; Andreassen OA; Westlye LT; Kaufmann T; Farde L; Flyckt L; Engberg G; Erhardt SS; Fatouros-Bergman H; Cervenka S; Schwieler L; Piehl F; Agartz I; Collste K; Victorsson P; Malmqvist A; Hedberg M; Orhan F; Sellgren CM
Article: BIOANALYSIS. 2020;12(6):379-392
A novel, robust method for quantification of multiple kynurenine pathway metabolites in the cerebrospinal fluid
Schwieler L; Trepci A; Krzyzanowski S; Hermansson S; Granqvist M; Piehl F; Venckunas T; Brazaitis M; Kamandulis S; Lindqvist D; Jones AD; Erhardt S; Brundin L
Article: INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH. 2020;13:1178646920978241
Quantification of Plasma Kynurenine Metabolites Following One Bout of Sprint Interval Exercise
Trepci A; Imbeault S; Wyckelsma VL; Westerblad H; Hermansson S; Andersson DC; Piehl F; Venckunas T; Brazaitis M; Kamandulis S; Brundin L; Erhardt S; Schwieler L
Article: NATURE NEUROSCIENCE. 2019;22(10):1617-1623
Common brain disorders are associated with heritable patterns of apparent aging of the brain
Kaufmann T; van der Meer D; Nhat TD; Schwarz E; Lund MJ; Agartz I; Alnaes D; Barch DM; Baur-Streubel R; Bertolino A; Bettella F; Beyer MK; Boen E; Borgwardt S; Brandt CL; Buitelaar J; Celius EG; Cervenka S; Conzelmann A; Cordova-Palomera A; Dale AM; de Quervain DJF; Carlo P; Djurovic S; Dorum ES; Eisenacher S; Elvsashagen T; Espeseth T; Fatouros-Bergman H; Flyckt L; Franke B; Frei O; Haatveit B; Haberg AK; Harbo HF; Hartman CA; Heslenfeld D; Hoekstra PJ; Hogestol EA; Jernigan TL; Jonassen R; Jonsson EG; Kirsch P; Ktoszewska I; Kolskar KK; Landro NI; Hellard S; Lesch K-P; Lovestone S; Lundervold A; Lundervold AJ; Maglanoc LA; Malt UF; Mecocci P; Melle I; Meyer-Lindenberg A; Moberget T; Norbom LB; Nordvik JE; Nyberg L; Oosterlaan J; Papalino M; Papassotiropoulos A; Pauli P; Pergola G; Persson K; Richard G; Rokicki J; Sanders A-M; Selbaek G; Shadrin AA; Smeland OB; Soininen H; Sowa P; Steen VM; Tsolaki M; Ulrichsen KM; Vellas B; Wang L; Westman E; Ziegler GC; Zink M; Andreassen OA; Westlye LT; Farde L; Flyckts L; Engberg G; Erhardt S; Fatouros-Bergmann H; Schwieler L; Piehl F; Collste K; Victorsson P; Malmqvist A; Hedberg M; Orhan F
Article: SCHIZOPHRENIA RESEARCH. 2019;210:221-227
Increased peripheral levels of TARC/CCL17 in first episode psychosis patients
Malmqvist A; Schwieler L; Orhan F; Fatouros-Bergman H; Bauer M; Flyckt L; Cervenka S; Engberg G; Piehl F; Erhardt S; Farde L; Flyckt L; Engberg G; Erhardt S; Fatouros-Bergman H; Cervenka S; Schwieler L; Piehl F; Agartz I; Collste K; Victorsson P; Malmqvist A; Hedberg M; Orhan F
Article: JAMA PSYCHIATRY. 2019;76(7):739-748
Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk
Alnaes D; Kaufmann T; van der Meer D; Cordova-Palomera A; Rokicki J; Moberget T; Bettella F; Agartz I; Barch DM; Bertolino A; Brandt CL; Cervenka S; Djurovic S; Nhat TD; Eisenacher S; Fatouros-Bergman H; Flyckt L; Di Giorgio A; Haatveit B; Jonsson EG; Kirsch P; Lund MJ; Meyer-Lindenberg A; Pergola G; Schwarz E; Smeland OB; Quarto T; Zink M; Andreassen OA; Westlye LT; Farde L; Collste K; Victorsson P; Engberg G; Erhardt S; Malmqvist A; Hedberg M; Orhan F; Sellgren CM; Schwieler L; Piehl F
Article: TRANSLATIONAL PSYCHIATRY. 2019;9(1):37
Peripheral and central levels of kynurenic acid in bipolar disorder subjects and healthy controls
Sellgren CM; Gracias J; Jungholm O; Perlis RH; Engberg G; Schwieler L; Landen M; Erhardt S
Article: TRANSLATIONAL PSYCHIATRY. 2019;9(1):12
Reproducible grey matter patterns index a multivariate, global alteration of brain structure in schizophrenia and bipolar disorder
Schwarz E; Nhat TD; Pergola G; Westlye LT; Kaufmann T; Wolfers T; Brecheisen R; Quarto T; Ing AJ; Di Carlo P; Gurholt TP; Harms RL; Noirhomme Q; Moberget T; Agartz I; Andreassen OA; Bellani M; Bertolino A; Blasi G; Brambilla P; Buitelaar JK; Cervenka S; Flyckt L; Frangou S; Franke B; Hall J; Heslenfeld DJ; Kirsch P; McIntosh AM; Noethen MM; Papassotiropoulos A; de Quervain DJ-F; Rietschel M; Schumann G; Tost H; Witt SH; Zink M; Meyer-Lindenberg A; Bettella F; Brandt CL; Clarke T-K; Coynel D; Degenhardt F; Djurovic S; Eisenacher S; Fastenrath M; Fatouros-Bergman H; Forstner AJ; Frank J; Gambi F; Gelao B; Geschwind L; Di Giannantonio M; Di Giorgio A; Hartman CA; Heilmann-Heimbach S; Herms S; Hoekstra PJ; Hoffmann P; Hoogman M; Jonsson EG; Loos E; Maggioni E; Oosterlaan J; Papalino M; Rampino A; Romaniuk L; Selvaggi P; Sepede G; Sonderby IE; Spalek K; Sussmann JE; Thompson PM; Vasquez AA; Vogler C; Whalley H; Farde L; Flyckt L; Engberg G; Erhardt S; Fatouros-Bergman H; Cervenka S; Schwieler L; Agartz I; Collste K; Victorsson P; Malmqvist A; Hedberg M; Orhan F
Article: INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH. 2019;12:1178646919891169
Lipopolysaccharide Increases Cortical Kynurenic Acid and Deficits in Reference Memory in Mice
Peyton L; Oliveros A; Tufvesson-Alm M; Schwieler L; Starski P; Engberg G; Erhardt S; Choi D-S
Article: BIOLOGICAL PSYCHIATRY. 2018;84(9):644-654
Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium
van Erp TGM; Walton E; Hibar DP; Schmaal L; Jiang W; Glahn DC; Pearlson GD; Yao N; Fukunaga M; Hashimoto R; Okada N; Yamamori H; Bustillo JR; Clark VP; Agartz I; Mueller BA; Cahn W; de Zwarte SMC; Pol HEH; Kahn RS; Ophoff RA; van Haren NEM; Andreassen OA; Dale AM; Nhat TD; Gurholt TP; Hartberg CB; Haukvik UK; Jorgensen KN; Lagerberg TV; Melle I; Westlye LT; Gruber O; Kraemer B; Richter A; Zilles D; Calhoun VD; Crespo-Facorro B; Roiz-Santianez R; Tordesillas-Gutierrez D; Loughland C; Carr VJ; Catts S; Cropley VL; Fullerton JM; Green MJ; Henskens FA; Jablensky A; Lenroot RK; Mowry BJ; Michie PT; Pantelis C; Quide Y; Schall U; Scott RJ; Cairns MJ; Seal M; Tooney PA; Rasser PE; Cooper G; Weickert CS; Weickert TW; Morris DW; Hong E; Kochunov P; Beard LM; Gur RE; Gur RC; Satterthwaite TD; Wolf DH; Belger A; Brown GG; Ford JM; Macciardi F; Mathalon DH; O'Leary DS; Potkin SG; Preda A; Voyvodic J; Lim KO; McEwen S; Yang F; Tan Y; Tan S; Wang Z; Fan F; Chen J; Xiang H; Tang S; Guo H; Wan P; Wei D; Bockholt HJ; Ehrlich S; Wolthusen RPF; King MD; Shoemaker JM; Sponheim SR; De Haan L; Koenders L; Machielsen MW; van Amelsvoort T; Veltman DJ; Assogna F; Banaj N; de Rossi P; Iorio M; Piras F; Spalletta G; McKenna PJ; Pomarol-Clotet E; Salvador R; Corvin A; Donohoe G; Kelly S; Whelan CD; Dickie EW; Rotenberg D; Voineskos AN; Ciufolini S; Radua J; Dazzan P; Murray R; Marques TR; Simmons A; Borgwardt S; Egloff L; Harrisberger F; Riecher-Roessler A; Smieskova R; Alpert KI; Wang L; Jonsson EG; Koops S; Sommer IEC; Bertolino A; Bonvino A; Di Giorgio A; Neilson E; Mayer AR; Stephen JM; Kwon JS; Yun J-Y; Cannon DM; McDonald C; Lebedeva I; Tomyshev AS; Akhadov T; Kaleda V; Fatouros-Bergman H; Flyckt L; Busatto GF; Rosa PGP; Serpa MH; Zanetti MV; Hoschl C; Skoch A; Spaniel F; Tomecek D; Hagenaars SP; McIntosh AM; Whalley HC; Lawrie SM; Knoechel C; Oertel-Knoechel V; Staeblein M; Howells FM; Stein DJ; Temmingh HS; Uhlmann A; Lopez-Jaramillo C; Dima D; McMahon A; Faskowitz JI; Gutman BA; Jahanshad N; Thompson PM; Turner JA
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2018;138(5):432-440
Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosis
Orhan F; Schwieler L; Fatouros-Bergman H; Malmqvist A; Cervenka S; Collste K; Flyckt L; Farde L; Sellgren CM; Piehl F; Engberg G; Erhardt S
Article: NEUROPHARMACOLOGY. 2018;138:130-139
Importance of kynurenine 3-monooxygenase for spontaneous firing and pharmacological responses of midbrain dopamine neurons: L Check for Relevance for schizophrenia
Tufvesson-Alm M; Schwieler L; Schwarcz R; Goiny M; Erhardt S; Engberg G
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2018;115(22):E5154-E5163
Mapping cortical brain asymmetry in 17,141 healthy individuals worldwide via the ENIGMA Consortium
Kong X-Z; Mathias SR; Guadalupe T; Glahn DC; Franke B; Crivello F; Tzourio-Mazoyer N; Fisher SE; Thompson PM; Francks C
Article: MOLECULAR PSYCHIATRY. 2018;23(5):1244-1250
CSF GABA is reduced in first-episode psychosis and associates to symptom severity
Orhan F; Fatouros-Bergman H; Goiny M; Malmqvist A; Piehl F; Cervenka S; Collste K; Victorsson P; Sellgren CM; Flyckt L; Erhardt S; Engberg G
Article: PSYCHOLOGICAL MEDICINE. 2018;48(1):82-94
Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium
Walton E; Hibar DP; van Erp TGM; Potkin SG; Roiz-Santianez R; Crespo-Facorro B; Suarez-Pinilla P; van Haren NEM; de Zwarte SMC; Kahn RS; Cahn W; Doan NT; Jorgensen KN; Gurholt TP; Agartz I; Andreassen OA; Westlye LT; Melle I; Berg AO; Morch-Johnsen L; Faerden A; Flyckt L; Fatouros-Bergman H; Jonsson EG; Hashimoto R; Yamamori H; Fukunaga M; Jahanshad N; De Rossi P; Piras F; Banaj N; Spalletta G; Gur RE; Gur RC; Wolf DH; Satterthwaite TD; Beard LM; Sommer IE; Koops S; Gruber O; Richter A; Kraemer B; Kelly S; Donohoe G; McDonald C; Cannon DM; Corvin A; Gill M; Di Giorgio A; Bertolino A; Lawrie S; Nickson T; Whalley HC; Neilson E; Calhoun VD; Thompson PM; Turner JA; Ehrlich S
Article: JOURNAL OF NEUROIMMUNOLOGY. 2017;313:1-9
LPS-induced cortical kynurenic acid and neurogranin-NFAT signaling is associated with deficits in stimulus processing during Pavlovian conditioning
Oliveros A; Wininger K; Sens J; Larsson MK; Liu XC; Choi S; Faka A; Schwieler L; Engberg G; Erhardt S; Choi DS
Article: MALARIA JOURNAL. 2017;16(1):303
Cerebrospinal fluid kynurenine and kynurenic acid concentrations are associated with coma duration and long-term neurocognitive impairment in Ugandan children with cerebral malaria
Holmberg D; Franzen-Rohl E; Idro R; Opoka RO; Bangirana P; Sellgren CM; Wickstrom R; Farnert A; Schwieler L; Engberg G; John CC
Article: MOLECULAR PSYCHIATRY. 2017;22(6):850-856
Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [¹¹C]PBR28
Collste K; Plaven-Sigray P; Fatouros-Bergman H; Victorsson P; Schain M; Forsberg A; Amini N; Aeinehband S; Erhardt S; Halldin C; Flyckt L; Farde L; Cervenka S
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2017;135(5):439-447
Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium
Walton E; Hibar DP; van Erp TGM; Potkin SG; Roiz-Santianez R; Crespo-Facorro B; Suarez-Pinilla P; Van Haren NEM; de Zwarte SMC; Kahn RS; Cahn W; Doan NT; Jorgensen KN; Gurholt TP; Agartz I; Andreassen OA; Westlye LT; Melle I; Berg AO; Morch-Johnsen L; Faerden A; Flyckt L; Fatouros-Bergman H; Jonsson EG; Hashimoto R; Yamamori H; Fukunaga M; Preda A; De Rossi P; Piras F; Banaj N; Ciullo V; Spalletta G; Gur RE; Gur RC; Wolf DH; Satterthwaite TD; Beard LM; Sommer IE; Koops S; Gruber O; Richter A; Kraemer B; Kelly S; Donohoe G; McDonald C; Cannon DM; Corvin A; Gill M; Di Giorgio A; Bertolino A; Lawrie S; Nickson T; Whalley HC; Neilson E; Calhoun VD; Thompson PM; Turner JA; Ehrlich S
Article: PSYCHIATRY RESEARCH. 2017;247:105-112
Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity
Kegel ME; Johansson V; Wetterberg L; Bhat M; Schwieler L; Cannon TD; Schuppe-Koistinen I; Engberg G; Landen M; Hultman CM; Erhardt S
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2016;84(5):262-271
Tryptophan Metabolism Along the Kynurenine Pathway Downstream of Toll-like Receptor Stimulation in Peripheral Monocytes
Orhan F; Bhat M; Sandberg K; Stahl S; Piehl F; Svensson C; Erhardt S; Schwieler L
Article: NEUROCHEMICAL RESEARCH. 2016;41(9):2243-2255
Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice
Larsson MK; Faka A; Bhat M; Imbeault S; Goiny M; Orhan F; Oliveros A; Stahl S; Liu XC; Choi DS; Sandberg K; Engberg G; Schwieler L; Erhardt S
Article: JOURNAL OF NEUROINFLAMMATION. 2016;13(1):51
Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients
Schwieler L; Samuelsson M; Frye MA; Bhat M; Schuppe-Koistinen I; Jungholm O; Johansson AG; Landen M; Sellgren CM; Erhardt S
Article: JOURNAL OF PSYCHIATRY & NEUROSCIENCE. 2015;40(2):126-133
Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia - significance for activation of the kynurenine pathway
Schwieler L; Larsson MK; Skogh E; Kegel ME; Orhan F; Abdelmoaty S; Finn A; Bhat M; Samuelsson M; Lundberg K; Dahl M-L; Sellgren C; Schuppe-Koistinen I; Svensson CI; Erhardt S; Engberg G
Article: INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH. 2015;8:49-52
Chronic Antipsychotic Treatment in the Rat - Effects on Brain Interleukin-8 and Kynurenic Acid.
Larsson MK; Schwieler L; Goiny M; Erhardt S; Engberg G
Article: BRAIN, BEHAVIOR, AND IMMUNITY. 2014;36:80-89
Behavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment - Role of brain kynurenic acid
Liu X-C; Holtze M; Powell SB; Terrando N; Larsson MK; Persson A; Olsson SK; Orhan F; Kegel M; Asp L; Goiny M; Schwieler L; Engberg G; Karlsson H; Erhardt S
Article: INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH. 2014;7:15-22
Imbalanced kynurenine pathway in schizophrenia.
Kegel ME; Bhat M; Skogh E; Samuelsson M; Lundberg K; Dahl M-L; Sellgren C; Schwieler L; Engberg G; Schuppe-Koistinen I; Erhardt S
Journal article: BRAIN, BEHAVIOR, AND IMMUNITY. 2013;32:e16-e17
57. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections perceived as conversion disorder. A case study of a young woman
Bejerot S; Hesselmark E; Wallén H; Mobarrez F; Landén M; Schwieler L; Nybom R; Wetterberg L
Article: INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH. 2013;6:89-96
Sustained elevation of kynurenic Acid in the cerebrospinal fluid of patients with herpes simplex virus type 1 encephalitis.
Atlas A; Franzen-Röhl E; Söderlund J; Jönsson EG; Samuelsson M; Schwieler L; Sköldenberg B; Engberg G
Article: JOURNAL OF INTERNAL MEDICINE. 2012;272(4):394-401
Elevated cerebrospinal fluid kynurenic acid levels in patients with tick-borne encephalitis
Holtze M; Mickiene A; Atlas A; Lindquist L; Schwieler L
Article: JOURNAL OF PSYCHIATRY & NEUROSCIENCE. 2012;37(1):53-57
Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls
Holtze M; Saetre P; Engberg G; Schwieler L; Werge T; Andreassen OA; Hall H; Terenius L; Agartz I; Jonsson EG; Schalling M; Erhardt S
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2009;12(4):501-512
Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia
Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
Article: JOURNAL OF NEUROSCIENCE RESEARCH. 2008;86(16):3674-3683
Induction of the Kynurenine Pathway by Neurotropic Influenza A Virus Infection
Holtze M; Asp L; Schwieler L; Engberg G; Karlsson H
Article: LIFE SCIENCES. 2008;83(5-6):170-175
Clozapine interacts with the glycine site of the NMDA receptor: Electrophysiological studies of dopamine neurons in the rat ventral tegmental area
Schwieler L; Linderholm KR; Nilsson-Todd LK; Erhardt S; Engberg G
Article: PHYSIOLOGY AND BEHAVIOR. 2007;92(1-2):203-209
The kynurenic acid hypothesis of schizophrenia
Erhardt S; Schwieler L; Nilsson L; Linderholm K; Engberg G
Article: BRAIN, BEHAVIOR, AND IMMUNITY. 2007;21(1):86-91
Acute psychotic symptoms in HIV-1 infected patients are associated with increased levels of kynurenic acid in cerebrospinal fluid
Atlas A; Gisslen M; Nordin C; Lindstrom L; Schwieler L
Article: SYNAPSE. 2006;59(5):290-298
Effects of COX-1 and COX-2 inhibitors on the firing of rat midbrain dopaminergic neurons - Possible involvement of endogenous kynurenic acid
Schwieler L; Erhardt S; Nilsson L; Linderholm K; Engberg G
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2005;8(3):329-339
Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms
Nilsson LK; Schwieler L; Engberg G; Linderholm KR; Erhardt S
Article: JOURNAL OF NEURAL TRANSMISSION. 2005;112(7):863-872
Prostaglandin-mediated control of rat brain kynurenic acid synthesis - opposite actions by COX-1 and COX-2 isoforms
Schwieler L; Erhardt S; Erhardt C; Engberg G
Article: BIOLOGICAL PSYCHIATRY. 2004;56(4):255-260
Endogenous kynurenic acid disrupts prepulse inhibition
Erhardt S; Schwieler L; Emanuelsson C; Geyer M
Article: SYNAPSE. 2004;52(2):114-122
Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex
Schwieler L; Engberg G; Erhardt S
Article: NEUROPSYCHOPHARMACOLOGY. 2003;28(10):1770-1777
Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid
Schwieler L; Erhardt S
Article: LIFE SCIENCES. 2003;72(24):2793-2801
The anaesthetic agent propofol interacts with GABA_B-receptors:: an electrophysiological study in rat
Schwieler L; Delbro DS; Engberg G; Erhardt S
Article: SYNAPSE. 2002;43(4):227-237
Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine
Erhardt S; Schwieler L; Engberg L
Show more

All other publications

Letter: BRAIN, BEHAVIOR, AND IMMUNITY. 2023;114:163-164
Preanalytic handling of clinical blood samples in assessing immunological proteins - Role of storage duration
Eren F; Schwieler L; Orhan F; Malmqvist A; Piehl F; Cervenka S; Sellgren CM; Fatouros-Bergman H; Engberg G; Erhardt S
Preprint: BIORXIV. 2023
Kynurenic acid promotes activity-dependent synaptic pruning in schizophrenia
Orhan F; Malwade S; Khanlarkhani N; Gkoga A; Jungholm O; Koskuvi M; Lehtonen Š; Schwieler L; Jardemark K; Tiihonen J; Koistinaho J; Erhardt S; Engberg G; Samudyata S; Sellgren C
Conference publication: BIOLOGICAL PSYCHIATRY. 2023;93(9):S24
Critical Role of Insulin as an Immunomodulatory Target in Treatment Resistant Depression
Tye S; Price J; Walker A; Sutor S; Erhardt S; Schwieler L; Cullen K; Voort JV; Frye M; Bobo W; Shiroma P
Conference publication: BIOLOGICAL PSYCHIATRY. 2023;93(9):S24
Ketamine Associated Change in Anhedonia and Suicidal Ideation are Associated With Peripheral Immune Cell mTOR Expression and Kynurenine Levels and Treatment Resistant Depression
Voort JV; Singh B; Riva-Posse P; Erhardt S; Schwieler L; Pazdernik V; Frye M; Tye S
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2023;48:356-357
Identification of Kat III as a Novel Pharmacological Target for the Treatment of Cognitive Impairment
Erhardt S; Gravenfors Y; Schwieler L
Corrigendum: MOLECULAR PSYCHIATRY. 2022;27(3):1855
GRK3 deficiency elicits brain immune activation and psychosis (May, 10.1038/s41380-021-01106-0, 2021)
Sellgren CM; Imbeault S; Larsson MK; Oliveros A; Nilsson IAK; Codeluppi S; Orhan F; Bhat M; Tufvesson-Alm M; Gracias J; Kegel ME; Zheng Y; Faka A; Svedberg M; Powell SB; Caldwell S; Kamenski ME; Vawter MP; Schulmann A; Goiny M; Svensson CI; Hokfelt T; Schalling M; Schwieler L; Cervenka S; Choi D-S; Landen M; Engberg G; Erhardt S
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2022;47:290-291
Dysregulation of the Kynurenine Pathway is Related to Persistent Cognitive Impairments After Tick Borne Encephalitis (TBE)
Schwieler L; Weidenfors JA; Griska V; Li X; Piehl F; Mickiene A; Erhardt S
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2022;47:277
Inflammation Moderates Antidepressant Response to Ketamine in a Rodent Model of Treatment-Resistant Depression: Bioenergetic and Inflammatory Markers of Response
Tye S; Price JB; Walker A; Kruse J; Cullen K; Frye M; Schwieler L; Erhardt S
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2022;47:378-379
Proteomic Plasma Profiling of Patients With First-Episode Psychosis Identifies Inflammatory Markers Associated With Illness Severity
Erhardt S; Schwieler L; Sellgren CM; Eren F; Cervenka S; Piehl F; Bergman HF; Orhan F; Engberg G
Preprint: MEDRXIV. 2021
Cerebrospinal fluid concentration of complement component 4A is increased in first-episode schizophrenia
Gracias J; Orhan F; Hörbeck E; Holmén-Larsson J; Khanlarkani N; Malwade S; Goparaju S; Schwieler L; Fatourus-Bergman H; Pelanis A; Goold C; Goulding A; Annerbrink K; Isgren A; Sparding T; Schalling M; Yañez VC; Göpfert J; Nilsson J; Brinkmalm A; Blennow K; Zetterberg H; Engberg G; Piehl F; Sheridan S; Perlis R; Cervenka S; Erhardt S; Landen M; Sellgren C
Letter: SCHIZOPHRENIA RESEARCH. 2019;208:490-492
Neurogranin as a potential synaptic marker in the cerebrospinal fluid of patients with a first episode psychosis
Santillo AF; Lundgren S; Xu C; Orhan F; Fatouros-Bergman H; Blennow K; Zetterberg H; Portelius E; Cervenka S; Jonsson EG; Erhardt S; Engberg G
Letter: BIOLOGICAL PSYCHIATRY. 2019;85(7):e35-e39
Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature of the Disease Process?
van Erp TGM; Walton E; Hibar DP; Schmaal L; Jiang W; Glahn DC; Pearlson GD; Yao N; Fukunaga M; Hashimoto R; Okada N; Yamamori H; Clark VP; Mueller BA; de Zwarte SMC; Ophoff RA; van Haren NEM; Andreassen OA; Gurholt TP; Gruber O; Kraemer B; Richter A; Calhoun VD; Crespo-Facorro B; Roiz-Santianez R; Tordesillas-Gutierrez D; Loughland C; Catts S; Fullerton JM; Green MJ; Henskens F; Jablensky A; Mowry BJ; Pantelis C; Quide Y; Schall U; Scott RJ; Cairns MJ; Seal M; Tooney PA; Rasser PE; Cooper G; Weickert CS; Weickert TW; Hong E; Kochunov P; Gur RE; Gur RC; Ford JM; Macciardi F; Mathalon DH; Potkin SG; Preda A; Fan F; Ehrlich S; King MD; De Haan L; Veltman DJ; Assogna F; Banaj N; de Rossi P; Iorio M; Piras F; Spalletta G; Pomarol-Clotet E; Kelly S; Ciufolini S; Radua J; Murray R; Marques TR; Simmons A; Borgwardt S; Schoenborn-Harrisberger F; Riecher-Roessler A; Smieskova R; Alpert KI; Bertolino A; Bonvino A; Di Giorgio A; Neilson E; Mayer AR; Yun J-Y; Cannon DM; Lebedeva I; Tomyshev AS; Akhadov T; Kaleda V; Fatouros-Bergman H; Flyckt L; Rosa PGP; Serpa MH; Zanetti MV; Hoschl C; Skoch A; Spaniel F; Tomecek D; McIntosh AM; Whalley HC; Knoechel C; Oertel-Knoechel V; Howells FM; Stein DJ; Temmingh HS; Uhlmann A; Lopez-Jaramillo C; Dima D; Faskowitz JI; Gutman BA; Jahanshad N; Thompson PM; Turner JA; Farde L; Flyckt L; Fatouros-Bergman H; Cervenka S; Collste K; Victorsson P; Engberg G; Erhardt S; Schwieler L; Malmqvist A; Hedberg M; Orhan F; Piehl F; Agartz I
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2019;44(SUPPL 1):490-491
Role of GRK3 in Brain Immune Activation and Psychosis
Erhardt S; Sellgren CM; Schwieler L; Imbeault S; Engberg G
Letter: SCHIZOPHRENIA RESEARCH. 2018;199:438-441
Cerebrospinal fluid levels of sphingolipids associate with disease severity in first episode psychosis patients
Checa A; Malmqvist A; Flyckt L; Schwieler L; Samuelsson M; Skogh E; Cervenka S; Dahl M-L; Piehl F; Erhardt S; Wheelock CE
Review: NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2018;90:212-220
Bioenergetics and synaptic plasticity as potential targets for individualizing treatment for depression
Price JB; Bronars C; Erhardt S; Cullen KR; Schwieler L; Berk M; Walder K; McGee SL; Frye MA; Tye SJ
Letter: SCHIZOPHRENIA RESEARCH. 2018;195:406-408
First-episode psychosis patients display increased plasma IL-18 that correlates with cognitive dysfunction
Orhan F; Fatouros-Bergman H; Schwieler L; Cervenka S; Flyckt L; Sellgren CM; Engberg G; Erhardt S
Preprint: BIORXIV. 2017
Mapping Cortical Brain Asymmetry in 17,141 Healthy Individuals Worldwide via the ENIGMA Consortium
Kong X-Z; Mathias S; Guadalupe T; Abé C; Agartz I; Akudjedu T; Andre A; Saud A; Allen N; Ames D; Andreassen O; Arias Vasquez A; Armstrong N; Bergo F; Bastin M; Batalla A; Bauer J; Baune B; Baur R; Biederman J; Blaine S; Boedhoe P; Bøen E; Bose A; Bralten J; Brandeis D; Brem S; Brodaty H; Bröhl H; Brooks S; Buitelaar J; Bürger C; Bülow R; Calhoun V; Calvo A; Canales-Rodríguez EJ; Canive J; Cannon D; Caparelli E; Castellanos F; Cavalleri G; Cendes F; Chaim-Avancini TM; Chantiluke K; Chen Q-L; Chen X; Cheng Y; Christakou A; Clark V; Coghill D; Connolly C; Conzelmann A; Cόrdova-Palomera A; Cousijn J; Crow T; Cubillo A; Dannlowski U; de Bruttopilo SA; Zeeuw PD; Deary I; Delanty N; Demeter D; Martino AD; Dickie E; Dietsche B; Doan T; Doherty C; Doyle A; Durston S; Earl E; Ehrlich S; Ekman CJ; Elvsåshagen T; Epstein J; Fair D; Faraone S; Fatouros-Bergman H; Fernndez G; Busatto Filho G; Flyckt L; Forster K; Jean-Paul F; Foxe J; Fuentes-Claramonte P; Fullerton J; Garavan H; Garcia DDS; Gotlib I; Goudriaan A; Jorgen Grabe H; Groenewold N; Grotegerd D; Gruber O; Gurholt T; Haavik J; Hahn T; Hansell N; Harris M; Hartman C; Hernandez MDCV; Heslenfeld D; Hester R; Hibar DP; Ho B-C; Ho T; Hoekstra P; van Holst R; Hoogman M; Hovik M; Howells F; Hugdahl K; Huyser C; Ingvar M; Irwin L; Ishikawa A; James A; Jahanshad N; Jernigan T; Jonsson E; Kahler C; Kaleda V; Kelly C; Kerich M; Keshavan M; Khadka S; Kircher T; Kohls G; Konrad K; Korucuoglu O; Kramer B; Krug A; Kwon JS; Lambregts-Rommelse N; Landen M; Lazaro L; Lebedeva I; Lenroot R; Lesch K-P; Li Q; Lim K; Liu J; Lochner C; London E; Lonning V; Lorenzetti V; Luciano M; Luijten M; Lundervold A; Mackey S; MacMaster F; Maingault S; Malpas C; Malt U; Mataix-Cols D; Martin-Santos R; Mayer A; McCarthy H; Mitchell P; Mueller B; Maniega SM; Mazoyer B; McDonald C; McLellan Q; McMahon K; McPhilemy G; Momenan R; Morales A; Narayanaswamy J; Moreira JCV; Nerland S; Nestor L; Nigg J; Nordvik J-E; Novotny S; Oberwelland E; O'Gorman R; Oosterlaan J; Oranje B; Orr C; Overs B; Pauli P; Paulus M; Plessen K; von Polier G; Pomarol-Clotet E; Qiu J; Radua J; Ramos-Quiroga JA; Reddy YCJ; Reif A; Roberts G; Rosa P; Rubia K; Sacchet M; Sachdev P; Salvador R; Schmaal L; Schweren L; Seidman L; Seitz J; Serpa MH; Shaw P; Shumskaya E; Silk T; Simmons A; Simulionyte E; Sinha R; Sjoerds Z; Smelror RE; Soliva JC; Solowij N; Sponheim S; Stein D; Stein E; Stevens M; Strike L; Sudre G; Sui J; Tamm L; Temmingh H; Thoma R; Tomyshev A; Tronchin G; Turner J; Uhlmann A; van Erp TGM; van den Heuvel O; van der Meer D; van Eijk L; Vance A; Veer I; Dic
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27:S722
Associations between central chemokine levels and glial activation in first episode psychosis - a positron emission tomography study
Collste K; Orhan F; Erhardt S; Schwieler L; Flyckt L; Farde L; Engberg G; Cervenka S
Conference publication: BIOLOGICAL PSYCHIATRY. 2017;81(10):S266-S267
Metformin Enhances Antidepressant Response Rate to Ketamine in a Rodent Model of Antidepressant Treatment Resistance
Price J; He C; Erhardt S; Schwieler L; Frye M; Tye S
Review: NEUROPHARMACOLOGY. 2017;112(Pt B):297-306
The kynurenine pathway in schizophrenia and bipolar disorder
Erhardt S; Schwieler L; Imbeault S; Engberg G
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2017;42:S220-S221
First-Episode Psychosis Patients Display Increased Plasma IL-18 That Correlates With Cognitive Dysfunctions
Schwieler L; Orhan F; Fatouros-Bergman H; Cervenka S; Flyckt L; Farde L; Sellgren CM; Engberg G; Erhardt S
Meeting abstract: EUROPEAN PSYCHIATRY. 2015;30:277
Cognitive Performance in Drug-naive First Episode Schizophrenia (FES) Patients
Fatouros-Bergman H; Cervenka C; Flyckt L; Edman G; Schwieler L; Ikonen P; Collste K; Piehl F; Agartz I; Engberg G; Erhardt S; Farde L
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2013;23:S14-S15
Intracerebroventricular administration of interleukin-1β elevates brain kynurenic acid and disrupts prepulse inhibition in C57BL/6 mice
Larsson M; Schwieler L; Engberg G; Powell SB; Erhardt S
Conference publication: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2012;15:128-129
Endogenous kynurenic acid induces a reduction in parvalbumin immunoreactivity in the rat frontal cortex
Orhan F; Kegel M; Larsson M; Schwieler L; Erhardt S
Conference publication: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2012;15:134
Central interleukin-6 activation in patients with chronic schizophrenia
Schwieler L; Skogh E; Samuelsson M; Kegel M; Erhardt S; Engberg G
Letter: SCHIZOPHRENIA RESEARCH. 2011;127(1-3):270-272
Kynurenine 3-monooxygenase (KMO) polymorphisms in schizophrenia: An association study
Holtze M; Saetre P; Erhardt S; Schwieler L; Werge T; Hansen T; Nielsen J; Djurovic S; Melle I; Andreassen OA; Hall H; Terenius L; Agartz I; Engberg G; Jonsson EG; Schalling M
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2008;18:S2-S3
The effect of influenza A/WSN/33 virus infections on the kynurenine pathway
Asp L; Holtze M; Schwieler L; Engberg G; Karlsson H
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S422-S423
Enhanced amphetamine-induced dopamine release in rat nucleus accumbens following subchronic elevation of kynurenic acid
Andersson LA; Nilsson LK; Schwieler L; Holtze M; Olsson SK; Olsson E; Linderholm K; Engberg G; Erhardt S
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S420-S421
Kynurenine pathway enzymes and levels of brain kynurenic acid following Influenza virus infection
Holtze M; Asp L; Engberg G; Karlsson H; Schwieler L
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S419-S420
Subchronic elevation of endogenous levels of kynurenic acid increase dopamine release in rat nucleus accumbens
Nilsson-Todd LK; Andersson LA; Schwieler L; Engberg G; Holtze M; Linderholm KR; Olsson E; Olsson SK; Erhardt S
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S219
Endogenous kynurenate regulates dopaminergic activity: implications for schizophrenia research
Erhardt S; Schwieler L; Nilsson LK; Andersson LA; Linderholm KR; Holtze M; Olsson E; Olsson SK; Engberg G
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S536-S537
Increased levels of kynurenic acid may account for neuropsychiatric symptoms in patients with tick-borne encephalitis
Schwieler L; Mickiene A; Holtze M; Atlas A; Engberg G
Thesis / dissertation: 2006
Endogenous kynurenic acid and schizophrenia : physiological and pharmacological aspects
Schwieler, Lilly
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2006;16:S435-S436
The response of clozapine on midbrain dopamine neurons depends on endogenous concentration of kynurenic acid
Schwieler L; Linderholm KR; Nilsson LK; Engberg G; Erhardt S
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2006;31:S126
Changes in brain kynurenic acid levels alter the response of clozapine on midbrain dopamine neurons
Engberg G; Erhardt S; Linderholm K; Nilsson L; Schwieler L
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2006;31:S45
Role of endogenous kynurenic acid in the control of dopaminergic neurotransmission
Erhardt S; Schwieler L; Linderholm K; Nilsson L; Engberg G
Conference publication: NORDIC JOURNAL OF PSYCHIATRY. 2006;60(4):334
Changes in brain kynurenic acid levels alter the response of clozapine on midbrain dopamine neurons
Linderholm KR; Erhardt S; Nilsson LK; Schwieler L; Engberg G
Conference publication: NORDIC JOURNAL OF PSYCHIATRY. 2006;60(4):337
Acute psychotic symptoms in HIV-1 infected patients are associated with increased levels of kynurenic acid in cerebrospinal fluid
Schwieler L; Atlas A; Nordin C; Lindstrom L; Gisslen M
Conference publication: NORDIC JOURNAL OF PSYCHIATRY. 2005;59(5):409
Kynurenate tonically modulates midbrain dopamine neurons
Erhardt S; Schwieler L; Linderholm KR; Nilsson LK; Engberg G
Conference publication: NORDIC JOURNAL OF PSYCHIATRY. 2004;58(2):94
Elevation of the endogenous NMDA-receptor antagonist kynurenic acid disrupts prepulse inhibition
Erhardt S; Schwieler L; Geyer M
Conference publication: NORDIC JOURNAL OF PSYCHIATRY. 2004;58(2):106-107
Prostaglandin-mediated control of rat brain kynurenic acid synthesis - opposite actions by COX-1 and COX-2 isoforms
Schwieler L; Erhardt S; Engberg G
Conference publication: NORDIC JOURNAL OF PSYCHIATRY. 2004;58(2):102
Clozapine affects noradrenergic locus coerulcus neurons via interactions with the NMDA receptor
Erhardt S; Nilsson LK; Schwieler L; Engberg G
Published conference paper: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. 2003;527:155-165
Kynurenic acid and schizophrenia
Erhardt S; Schwieler L; Engberg G
Conference publication: NORDIC JOURNAL OF PSYCHIATRY. 2001;55(2):90
Excitatory and inhibitory effects of nicotine on neuronal firing of A10 dopamine neurons are mediated via glutamate-and GABA-release, respectively
Erhardt S; Schwieler LH; Engberg G
Conference publication: NORDIC JOURNAL OF PSYCHIATRY. 2001;55(2):89
The intravenous anesthetic agent propofol induces regularization of the firing pattern and prevents burst activity of nigral dopamine neurons via a GABAB-receptor agonistic action
Engberg G; Erhardt S; Schwieler LH
Show more

Employments

Affiliated to Research, Department of Physiology and Pharmacology, Karolinska Institutet, 2024-2025

Degrees and Education

Docent, Karolinska Institutet, 2021
Doctor Of Philosophy, Department of Physiology and Pharmacology, Karolinska Institutet, 2006

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI